In this forward-looking conversation, A/Professor Raymond Schwartz, founding partner of Southern Neurology, shares his perspective on the rapidly evolving landscape of Parkinson’s disease research and care. As a highly experienced neurologist with a strong commitment to advancing patient outcomes, he offers a grounded yet optimistic view of where the field is heading—particularly in the area of disease-modifying therapies.  Throughout the discussion, A/Professor Schwartz highlights the critical difference between lifestyle, traditional symptomatic treatments and the emerging wave of disease-modifying trials aimed at slowing or even halting the progression of Parkinson’s disease. While current therapies play an essential role in managing day-to-day symptoms, he emphasises that participation in clinical trials represents a powerful opportunity to change the long-term trajectory of the condition—not just for individuals, but for the broader Parkinson’s community.

Volunteer for our research here: https://bit.ly/PDRC_EOI